Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination of sPLA2 activity and oxPL/apoB cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/event

Combination of sPLA2 activity and oxPL/apoB cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/event

US Patent 8361732 · Granted Jan 29, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for diagnosis of cardiovascular disease2025
Compositions and methods for diagnosis of cardiovascular disease2025
Antibodies to oxidation-specific epitopes2025
Antibodies to oxidation-specific epitopes2025
Method of treating rheumatoid arthritis using antibodies to oxidized phospholipi2025
Method of treating rheumatoid arthritis using antibodies to oxidized phospholipi2025
B cell depleting agent for the treatment of atherosclerosis2024
B cell depleting agent for the treatment of atherosclerosis2024
Inhibition of oxidation-specific epitopes to treat ischemic reperfusion injury2024
Inhibition of oxidation-specific epitopes to treat ischemic reperfusion injury2024
Methods and pharmaceutical compositions for the treatment of obesity2023
Methods and pharmaceutical compositions for the treatment of obesity2023